Arabic journal
العودة إلى المقالات
Sex-Specific Effects of APOE4 on Multimodal Biomarkers Across the Alzheimer's Disease Spectrum: A Comprehensive Interaction Analysis
نوع الإرسال:
المؤلفون
1 Radiological Science Department, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia
المستخلص
Background: The APOE4 allele represents the strongest genetic risk factor for Alzheimer's disease, though emerging evidence suggests its effects may be sex-dependent. This study comprehensively investigated sex-specific APOE4 effects across multimodal biomarkers in a well-characterized cohort spanning the AD continuum.
Methods: We analyzed 684 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) including cognitively normal (n=159), mild cognitive impairment (MCI, n=443), and Alzheimer's disease (AD, n=82) individuals. Sixteen clinical variables encompassing neuroimaging, cerebrospinal fluid biomarkers, metabolic profiles, and cardiovascular measures were examined.
Results: our analysis revealed significant sex-by-APOE4 interactions for the majority of biomarkers. Large effect sizes were found for total white matter (ε²=0.242), HDL cholesterol (ε²=0.186), total gray matter (η²=0.375), and total CSF volume (η²=0.222). The MCI stage showed the most pronounced interactions, with significant effects on FDG-PET metabolism (ε²=0.040), phosphorylated tau (ε²=0.123), and lipid profiles. Phosphorylated tau demonstrated substantial sex-specific genetic effects across all diagnostic groups.
Conclusions: Our findings reveal widespread, robust sex-dependent APOE4 effects, particularly during the MCI stage. These results emphasize the crucial importance of considering sex as an effect modifier in AD genetic risk and highlight potential targets for sex-specific therapeutic interventions.
المواضيع الرئيسية
Special Education & Home Economy
الكلمات المفتاحية
Multimodal Biomarkers
Alzheimer's Disease
Neuroimaging
Cerebrospinal Fluid Biomarkers
Metabolic Profiles
Volume 4, Proceeding of the 16th Annual Meeting of Radiology Society of Saudi Arabia (RSSA)
منشور
صفحات 79 - 91
رؤى المقالة
عدد مرات مشاهدة المقال
3
تحميلات PDF
0
المراجع
- 1.Gauthier S, Webster C, Servaes S, Morais JA, Rosa-Neto P. World Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support. London: Alzheimer's Disease International; 2022.
- 2.Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106–118.
- 3.Neu SC, Pa J, Kukull W, et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis. JAMA Neurol. 2017;74(10):1178–1189.
- 4.Buckley RF, Mormino EC, Rabin JS, et al. Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol. 2019;76(5):542–551.
- 5.Hohman TJ, Dumitrescu L, Barnes LL, et al. Sex-specific association of apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018;75(8):989–998.
- 6.Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535–562.
- 7.Bondi MW, Edmonds EC, Jak AJ, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42(1):275–289.
- 8.Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018;136(6):887–900.
- 9.Goyal MS, Blazey TM, Su Y, et al. Persistent metabolic youth in the aging female brain. Proc Natl Acad Sci USA. 2019;116(8):3251–3255.
- 10.Yin X, Wang R, Sun J, et al. APOE4 affects basal and NMDAR-mediated protein synthesis in neurons by perturbing calcium homeostasis. J Neurosci. 2021;41(42):8686–8709.
- 11.Zhao N, Liu CC, Van Ingelgom AJ, et al. Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron. 2017;96(1):115–129.
- 12.Tai LM, Thomas R, Marottoli FM, et al. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol. 2016;131(5):709–723.
- 13.Damoiseaux JS, Seeley WW, Zhou J, et al. Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J Neurosci. 2012;32(24):8254–8262.
- 14.Dubal DB, Broestl L, Worden K. Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition? Biol Sex Differ. 2012;3(1):24.
- 15.Mielke MM. Sex and gender differences in Alzheimer's disease dementia. Psychiatr Times. 2018;35(11):14–17.
- 16.Groot C, Sudre CH, Barkhof F, et al. Clinical phenotype, atrophy, and small vessel disease in APOEε4 carriers with Alzheimer disease. Neurology. 2018;91(20):e1851–e1859.
- 17.Miller KL, Alfaro-Almagro F, Bangerter NK, et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016;19(11):1523–1536.
- 18.Cavedo E, Lista S, Rojkova K, et al. Disrupted white matter structural networks in healthy older adult APOE ε4 carriers – An international multicenter DTI study. Neuroscience. 2017;357:119–133.
- 19.Li R, Singh M. Sex differences in cognitive impairment and Alzheimer's disease. Front Neuroendocrinol. 2014;35(3):385–403.
- 20.Davis EJ, Broestl L, Abdulai-Saiku S, et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease. Sci Transl Med. 2020;12(558):eaaz5677.
- 21.Guo L, Zhong MB, Zhang L, Zhang B, Liu D. Sex differences in Alzheimer's disease: insights from the multiomics landscape. Biol Psychiatry. 2022;91(1):61–71.